» Articles » PMID: 32603910

Controversy of Physiological Vs. Pharmacological Effects of BMP Signaling: Constitutive Activation of BMP Type IA Receptor-dependent Signaling in Osteoblast Lineage Enhances Bone Formation and Resorption, Not Affecting Net Bone Mass

Overview
Journal Bone
Date 2020 Jul 1
PMID 32603910
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Bone morphogenetic proteins (BMPs) were first described over 50 years ago as potent inducers of ectopic bone formation when administrated subcutaneously. Preclinical studies have extensively examined the osteoinductive properties of BMPs in vitro and new bone formation in vivo. BMPs (BMP-2, BMP-7) have been used in orthopedics over 15 years. While osteogenic function of BMPs has been widely accepted, our previous studies demonstrated that loss-of-function of BMP receptor type IA (BMPR1A), a potent receptor for BMP-2, increased net bone mass by significantly inhibiting bone resorption in mice, indicating a positive role of BMP signaling in bone resorption. The physiological role of BMPs (i.e. osteogenic vs. osteoclastogenic) is still largely unknown. The purpose of this study was to investigate the physiological role of BMP signaling in endogenous long bones during adult stages. For this purpose, we conditionally and constitutively activated the Smad-dependent canonical BMP signaling thorough BMPR1A in osteoblast lineage cells using the mutant mice (Col1CreER™:caBmpr1a). Because trabecular bones were largely increased in the loss-of-function mouse study for BMPR1A, we hypothesized that the augmented BMP signaling would affect endogenous trabecular bones. In the mutant bones, the Smad phosphorylation was enhanced within physiological level three-fold while the resulting gross morphology, bodyweights, bone mass/shape/length, serum calcium/phosphorus levels, collagen cross-link patterns, and healing capability were all unchanged. Interestingly, we found; 1) increased expressions of both bone formation and resorption markers in femoral bones, 2) increased osteoblast and osteoclast numbers together with dynamic bone formation parameters by trabecular bone histomorphometry, 3) modest bone architectural phenotype with reduced bone quality (i.e. reduced trabecular bone connectivity, larger diametric size but reduced cortical bone thickness, and reduced bone mechanical strength), and 4) increased expression of SOST, a downstream target of the Smad-dependent BMPR1A signaling, in the mutant bones. This study is clinically insightful because gain-of-function of BMP signaling within a physiological window does not increase bone mass while it alters molecular and cellular aspects of osteoblast and osteoclast functions as predicted. These findings help explain the high-doses of BMPs (i.e. pharmacological level) in clinical settings required to substantially induce a bone formation, concurrent with potential unexpected side effects (i.e. bone resorption, inflammation) presumably due to a broader population of cell-types exposed to the high-dose BMPs rather than osteoblastic lineage cells.

Citing Articles

Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts.

Lademann F, Rijntjes E, Kohrle J, Tsourdi E, Hofbauer L, Rauner M Commun Biol. 2024; 7(1):548.

PMID: 38719881 PMC: 11078941. DOI: 10.1038/s42003-024-06227-0.


Impact of PEG sensitization on the efficacy of PEG hydrogel-mediated tissue engineering.

Isaac A, Recalde Phillips S, Ruben E, Estes M, Rajavel V, Baig T Nat Commun. 2024; 15(1):3283.

PMID: 38637507 PMC: 11026400. DOI: 10.1038/s41467-024-46327-3.


Multiple roles of ALK3 in osteoarthritis.

Ruan X, Gu J, Chen M, Zhao F, Aili M, Zhang D Bone Joint Res. 2023; 12(7):397-411.

PMID: 37394235 PMC: 10315222. DOI: 10.1302/2046-3758.127.BJR-2022-0310.R1.


Augmentation of BMP Signaling in Cranial Neural Crest Cells Leads to Premature Cranial Sutures Fusion through Endochondral Ossification in Mice.

Ueharu H, Pan H, Liu X, Ishii M, Pongetti J, Kulkarni A JBMR Plus. 2023; 7(4):e10716.

PMID: 37065628 PMC: 10097634. DOI: 10.1002/jbm4.10716.


Increased BMP-Smad signaling does not affect net bone mass in long bones.

Omi M, Koneru T, Lyu Y, Haraguchi A, Kamiya N, Mishina Y Front Physiol. 2023; 14:1145763.

PMID: 37064883 PMC: 10101206. DOI: 10.3389/fphys.2023.1145763.


References
1.
Wozney J, Rosen V, Celeste A, Mitsock L, Whitters M, Kriz R . Novel regulators of bone formation: molecular clones and activities. Science. 1988; 242(4885):1528-34. DOI: 10.1126/science.3201241. View

2.
Li X, Ominsky M, Niu Q, Sun N, Daugherty B, DAgostin D . Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008; 23(6):860-9. DOI: 10.1359/jbmr.080216. View

3.
Fujita K, Janz S . Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer. 2007; 6:71. PMC: 2173906. DOI: 10.1186/1476-4598-6-71. View

4.
Yamauchi M, Taga Y, Hattori S, Shiiba M, Terajima M . Analysis of collagen and elastin cross-links. Methods Cell Biol. 2018; 143:115-132. DOI: 10.1016/bs.mcb.2017.08.006. View

5.
Maes C, Kobayashi T, Kronenberg H . A novel transgenic mouse model to study the osteoblast lineage in vivo. Ann N Y Acad Sci. 2007; 1116:149-64. DOI: 10.1196/annals.1402.060. View